Article

Amblyopia screening program in Lancaster focuses on elementary schools

A pilot program has been set up in Lancaster, PA, to catch cases of amblyopia early in city school children.

Lancaster, PA-Once a child reaches age 9 to 11, there is more of a risk of permanent vision loss when treating amblyopia, according to David Silbert, MD. This is why Dr. Silbert set up a pilot program to catch cases of amblyopia early in city school children.

The program is under way at Washington Elementary School, Lancaster, PA, where 100 kindergarten and first-grade students are being screened on-site by Dr. Silbert's team. If they show signs of amblyopia, Dr. Silbert and his colleagues will provide treatment, either at the school or at Lancaster's Family Eye Group.

"By linking the screening and the treatment in one program and getting the school involved, we feel we can do a better job treating amblyopia," Dr. Silbert said. "Children can't go to school without the proper vaccinations. Why should a child go to school with lazy eye and not be treated for it?"

Dr. Silbert wishes he could screen children as early as 3 years old, but will settle for getting them in kindergarten. He suggests parents have all children screened but to bring them in as soon as they see one eye drifting or crossing.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.